Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-erythrocyte dexamethasone in ataxia telangiectasia (phase 3, randomized, placebo-controlled)
2015-005241-31Phase 3Completed
- Sponsor
- EryDel S.p.A.
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in ataxia-telangiectasia (AT) comparing Intra-erythrocyte dexamethasone sodium phosphate with Placebo (2 arms). Primary endpoint: Primary efficacy endpoint. Started May 2016; status: completed.
02
Drugs
dexamethasone sodium phosphate
03
Conditions
ataxia-telangiectasia (AT)
Beyond the preview
Go deeper on 2015-005241-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005241-31.